A Randomized Controlled Trial of Nicotinamide Supplementation in Early Parkinson's Disease

Sponsor / Institution: Haukeland University Hospital

Purpose

Investigate if NR supplementation will correct NAD deficiency and thereby slow progression of PD symptoms. Determine if NR delays PD disease progression measured by clinical monitoring tools (MDS-UPDRS). This trial will also collect biological material from participants to see if NR supplementation rectifies NAD deficiency and metabolism deficiencies.

Study Design

Double blind, parallel assignment

Dose

1000mg/day

Length of Intervention

52 weeks

Intrinsic Capacity

Locomotion

Status

Recruiting

Condition or Disease 

Parkinson Disease

Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.

Clinical Studies, Locomotion, Not Yet RecruitingANAD Staff